US-20260124381-A1 - MESH NETWORK COORDINATION SYSTEM FOR INJECTABLE MEDICATION ADMINISTRATION AND DRUG INTERACTION PREVENTION

Abstract

A mesh network medication coordination system enables communication between intelligent injection devices, monitoring systems, patient devices, or healthcare provider devices to prevent adverse drug interactions in hospital settings. The system includes mesh network infrastructure supporting multiple networked devices, dosage measurement devices that directly measure or infer dosage administration including injection completion detection, medication volume measurement, administration timing data, or patient biometric responses, or a coordination module that coordinates medication administration timing across multiple devices. The system features drug interaction analysis capabilities, real-time monitoring of patient vital signs and medication effectiveness, alert generation for potential interactions and dosing conflicts, or data synchronization across all networked devices. This integrated approach optimizes dosing intervals, prevents conflicting medication schedules, synchronizes administration events, or maintains consistent medication administration data across the mesh network to enhance patient safety and treatment efficacy.

Inventors

• Jeremy Corbett

Assignees

• DATADOSE, LLC

Dates

Publication Date

20260507

Application Date

20250829

Claims (20)

1. 1 . A mesh network medication coordination system, comprising: a mesh network infrastructure configured to enable communication between a plurality of networked devices, the networked devices including one or more intelligent injection devices, monitoring systems, patient devices, or healthcare provider devices; one or more dosage measurement devices configured to directly measure or infer dosage administration including one or more of injection completion detection, medication volume measurement, administration timing data, or patient biometric responses; and a coordination module configured to coordinate medication administration timing based on data from the networked devices.
2. 2 . The system of claim 1 , wherein the mesh network infrastructure is configured to support one or more of wireless communication protocols, Bluetooth connectivity, Wi-Fi networks, or cellular data transmission.
3. 3 . The system of claim 1 , wherein the dosage measurement devices are configured to detect one or more of plunger movement, medication flow rates, injection pressure, or completion status indicators.
4. 4 . The system of claim 1 , wherein the coordination module is further configured to synchronize medication schedules across multiple networked devices.
5. 5 . The system of claim 1 , wherein the networked devices include one or more of smart syringes, insulin pumps, wearable monitors, or mobile health applications.
6. 6 . The system of claim 1 , wherein the coordination module is configured to optimize dosing intervals based on one or more of patient response data, medication interactions, or treatment protocols.
7. 7 . The system of claim 1 , further comprising a data synchronization module configured to maintain consistent medication administration records across all networked devices.
8. 8 . The system of claim 1 , wherein the mesh network infrastructure is configured to automatically establish connections with newly detected compatible devices.
9. 9 . The system of claim 1 , wherein the dosage measurement devices are configured to transmit real-time administration data to one or more of healthcare providers, electronic health records, or patient monitoring systems.
10. 10 . A mesh network medication coordination system for preventing adverse drug interactions in hospital settings, comprising: a mesh network infrastructure configured to enable communication between one or more of intelligent injection devices, monitoring systems, patient devices, or healthcare provider devices; one or more dosage measurement devices configured to directly measure or infer dosage administration including one or more of injection completion detection, medication volume measurement, administration timing data, or patient biometric responses; a drug interaction analysis module configured to identify potential adverse interactions based on one or more of medication types, dosing schedules, patient characteristics, or administration timing; a coordination module configured to one or more of: coordinate medication administration timing across multiple devices; prevent conflicting medication schedules; optimize dosing intervals based on drug interaction analysis; or synchronize administration events across the mesh network; a real-time monitoring module configured to track one or more of patient vital signs, medication effectiveness, or adverse reaction indicators; an alert generation module configured to provide notifications for one or more of potential drug interactions, dosing conflicts, or administration timing recommendations; and a data synchronization module configured to maintain consistent medication administration data across all networked devices in the mesh.
11. 11 . The system of claim 10 , wherein the drug interaction analysis module is configured to access one or more of pharmaceutical databases, clinical decision support systems, or patient medical histories.
12. 12 . The system of claim 10 , wherein the real-time monitoring module is configured to integrate with one or more of vital sign monitors, laboratory systems, or patient observation devices.
13. 13 . The system of claim 10 , wherein the alert generation module is configured to provide notifications through one or more of visual displays, audio alerts, mobile notifications, or electronic health record alerts.
14. 14 . The system of claim 10 , wherein the coordination module is configured to automatically delay or reschedule conflicting medication administrations.
15. 15 . The system of claim 10 , wherein the drug interaction analysis module is configured to analyze interactions based on one or more of medication half-lives, metabolic pathways, or contraindication databases.
16. 16 . The system of claim 10 , wherein the data synchronization module is configured to update medication records in real-time across one or more of hospital information systems, pharmacy systems, or nursing documentation systems.
17. 17 . The system of claim 10 , wherein the alert generation module is configured to escalate alerts based on one or more of interaction severity levels, patient risk factors, or response timeframes.
18. 18 . The system of claim 10 , wherein the mesh network infrastructure is configured to maintain communication redundancy through multiple network pathways.
19. 19 . The system of claim 10 , wherein the real-time monitoring module is configured to correlate medication administration events with one or more of patient physiological responses, laboratory values, or clinical outcomes.
20. 20 . A computer-implemented method for coordinating medication administration using a mesh network to prevent adverse drug interactions in hospital settings, comprising: establishing, via a mesh network infrastructure, communication between one or more of intelligent injection devices, monitoring systems, patient devices, or healthcare provider devices; detecting, through one or more dosage measurement devices, medication administration events including one or more of injection completion detection, medication volume measurement, administration timing data, or patient biometric responses; analyzing, via a drug interaction analysis module, potential adverse interactions based on one or more of medication types, dosing schedules, patient characteristics, or administration timing; coordinating, through a coordination module, medication administration timing across multiple devices in the mesh network; preventing, via the coordination module, conflicting medication schedules between networked devices; optimizing, through the coordination module, dosing intervals based on drug interaction analysis results; synchronizing, via the coordination module, administration events across the mesh network; monitoring, through a real-time monitoring module, one or more of patient vital signs, medication effectiveness, or adverse reaction indicators; generating, via an alert generation module, notifications for one or more of potential drug interactions, dosing conflicts, or administration timing recommendations; maintaining, through a data synchronization module, consistent medication administration data across all networked devices in the mesh; and updating, across the mesh network, medication coordination protocols based on detected administration events and patient responses.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a continuation-in-part of U.S. patent application no. 19/281,005, filed on July 25, 2025, which is a continuation of U.S. patent application no. 19/031,862, filed on January 18, 2025, which is a continuation of U.S. patent application no. 19/030,829, filed on January 17, 2025, which claims the benefit of U.S. provisional application no. 63/715,505, filed on November 1, 2024, which are all hereby incorporated by reference in their entirety. FIELD The present disclosure relates generally to a management platform for injection devices, such as syringes, and, more particularly, to data reporting regarding administration completion of an injectable pharmaceutical. BACKGROUND Understanding administration of drugs and their interaction in the healthcare ecosystem are important in delivering beneficial patient care. Applicant appreciates that regular pharmaceutical therapy and a need for real time data management related to both timing of and compliance in dosing bundled with increased information sharing across the care continuum can provide valuable insight for improving care and, in turn, reducing fraud, waste, and abuse. SUMMARY In some aspects, the techniques described herein relate to a mesh network medication coordination system, including: a mesh network infrastructure configured to enable communication between a plurality of networked devices, the networked devices including one or more intelligent injection devices, monitoring systems, patient devices, or healthcare provider devices; one or more dosage measurement devices configured to directly measure or infer dosage administration including one or more of injection completion detection, medication volume measurement, administration timing data, or patient biometric responses; and a coordination module configured to coordinate medication administration timing based on data from the networked devices. In some aspects, the techniques described herein relate to a system, wherein the mesh network infrastructure is configured to support one or more of wireless communication protocols, Bluetooth connectivity, Wi-Fi networks, or cellular data transmission. In some aspects, the techniques described herein relate to a system, wherein the dosage measurement devices are configured to detect one or more of plunger movement, medication flow rates, injection pressure, or completion status indicators. In some aspects, the techniques described herein relate to a system, wherein the coordination module is further configured to synchronize medication schedules across multiple networked devices. In some aspects, the techniques described herein relate to a system, wherein the networked devices include one or more of smart syringes, insulin pumps, wearable monitors, or mobile health applications. In some aspects, the techniques described herein relate to a system, wherein the coordination module is configured to optimize dosing intervals based on one or more of patient response data, medication interactions, or treatment protocols. In some aspects, the techniques described herein relate to a system, further including a data synchronization module configured to maintain consistent medication administration records across all networked devices. In some aspects, the techniques described herein relate to a system, wherein the mesh network infrastructure is configured to automatically establish connections with newly detected compatible devices. In some aspects, the techniques described herein relate to a system, wherein the dosage measurement devices are configured to transmit real-time administration data to one or more of healthcare providers, electronic health records, or patient monitoring systems. In some aspects, the techniques described herein relate to a mesh network medication coordination system for preventing adverse drug interactions in hospital settings, including: a mesh network infrastructure configured to enable communication between one or more of intelligent injection devices, monitoring systems, patient devices, or healthcare provider devices; one or more dosage measurement devices configured to directly measure or infer dosage administration including one or more of injection completion detection, medication volume measurement, administration timing data, or patient biometric responses; a drug interaction analysis module configured to identify potential adverse interactions based on one or more of medication types, dosing schedules, patient characteristics, or administration timing; a coordination module configured to one or more of: coordinate medication administration timing across multiple devices; prevent conflicting medication schedules; optimize dosing intervals based on drug interaction analysis; or synchronize administration events across the mesh network; a real-time monitoring module configured to track one or more of patient vital signs, medication effectiveness, or adverse reaction indica